NeuroAccess Platform
Brain Cancers (e.g., Glioblastoma)
Key Facts
About Cordance Medical
Cordance Medical is pioneering a non-invasive, focused ultrasound-based platform to transiently and locally open the blood-brain barrier, a major obstacle in treating and diagnosing neurological disorders. The company's NeuroAccess system is designed to enhance drug delivery to the brain and allow for blood-based biomarker sampling ('sonobiopsy'), targeting indications like brain cancer, Alzheimer's, Parkinson's, and epilepsy. With a seasoned leadership team, key FDA regulatory recognition, and a platform approach, Cordance is positioning itself to unlock a significant unmet need in neurotherapeutics and diagnostics.
View full company profileAbout Cordance Medical
Cordance Medical is pioneering a non-invasive, focused ultrasound-based platform to transiently and locally open the blood-brain barrier, a major obstacle in treating and diagnosing neurological disorders. The company's NeuroAccess system is designed to enhance drug delivery to the brain and allow for blood-based biomarker sampling ('sonobiopsy'), targeting indications like brain cancer, Alzheimer's, Parkinson's, and epilepsy. With a seasoned leadership team, key FDA regulatory recognition, and a platform approach, Cordance is positioning itself to unlock a significant unmet need in neurotherapeutics and diagnostics.
View full company profileAbout Cordance Medical
Cordance Medical is pioneering a non-invasive, focused ultrasound-based platform to transiently and locally open the blood-brain barrier, a major obstacle in treating and diagnosing neurological disorders. The company's NeuroAccess system is designed to enhance drug delivery to the brain and allow for blood-based biomarker sampling ('sonobiopsy'), targeting indications like brain cancer, Alzheimer's, Parkinson's, and epilepsy. With a seasoned leadership team, key FDA regulatory recognition, and a platform approach, Cordance is positioning itself to unlock a significant unmet need in neurotherapeutics and diagnostics.
View full company profileAbout Cordance Medical
Cordance Medical is pioneering a non-invasive, focused ultrasound-based platform to transiently and locally open the blood-brain barrier, a major obstacle in treating and diagnosing neurological disorders. The company's NeuroAccess system is designed to enhance drug delivery to the brain and allow for blood-based biomarker sampling ('sonobiopsy'), targeting indications like brain cancer, Alzheimer's, Parkinson's, and epilepsy. With a seasoned leadership team, key FDA regulatory recognition, and a platform approach, Cordance is positioning itself to unlock a significant unmet need in neurotherapeutics and diagnostics.
View full company profile